(NaturalNews) Twenty-seven-year-old Gary Foster of Essex, U.K., recently died after participating in a government-funded drug trial that involved multiple double-doses of toxic chemotherapy. And while his family has since received the equivalent of nearly half a million dollars as a settlement -- or perhaps hush money, depending on how you look at it -- they are still calling on health safety officials to further investigate the case because they say Foster was "slowly poisoned to death."
Foster first tested positive for testicular cancer, upon which doctors told him that his chances of survival would improve if he participated in the trial. But a mere five months later, he ended up dead instead, which led his loved ones to seek answers. As of yet, however, Foster's parents have not been heard, and can only conclude that Dr. Stephen Harland, the doctor who oversaw Foster's care during the trial, carelessly killed their son without consequence.
And Foster was not the only study participant that died. According to a report in the U.K.
Daily Mail, 39-year-old Gareth Kingdon, father of a seven-month-old baby boy, was also killed as a result of taking the deadly chemotherapy drug bleomycin. In Kingdon's case, autopsy reports revealed that doctors severely overdosed him on the drug, which led to fatal lung damage.
Both Foster and Kingdon clearly died as a result of the poisonous drugs they were given by supposed licensed professionals, which in any other life sector would be considered murder. But because the deaths took place within the auspices of mainstream medicine, the victims' families are actually having to put considerable effort into spurring a proper investigation -- one that may never actually happen.
University College London Hospitals (UCLH), the network of hospitals that conducted the trial, has admitted responsibility for the errors, but at the same time has denied responsibility for what it says were "accidental" deaths.
Sources for this story include:http://www.dailymail.co.uk/health/article-1344344/Family-cancer-patie...
Have comments on this article? Post them here:
people have commented on this article.
Email this article to a friend
Now Available from 
